Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non–Small Cell Lung Cancer

Published:2020-06-01 Issue:6 Volume:6 Page:848
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Jabbour Salma K.¹,Berman Abigail T.²,Decker Roy H.³,Lin Yong¹⁴⁵,Feigenberg Steven J.²,Gettinger Scott N.⁶,Aggarwal Charu⁷,Langer Corey J.⁷,Simone Charles B.⁸,Bradley Jeffrey D.⁹,Aisner Joseph¹⁰,Malhotra Jyoti¹⁰

Affiliation:

1. Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey

2. Department of Radiation Oncology, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

3. Department of Therapeutic Radiology, Smilow Cancer Center, Yale School of Medicine, Yale University, New Haven, Connecticut

4. Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey

5. Biometrics Division, Rutgers Cancer Institute of New Jersey, Rutgers University, Piscataway, New Jersey

6. Section of Medical Oncology, Department of Medicine, Smilow Cancer Center, Yale School of Medicine, Yale University, New Haven, Connecticut

7. Division of Hematology Oncology, Department of Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia

8. Department of Radiation Oncology, New York Proton Center, New York, New York

9. Department of Radiation Oncology, Winship Cancer Institute, Emory School of Medicine, Emory University Atlanta, Georgia

10. Division of Medical Oncology, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, Rutgers University

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2761665/jamaoncology_jabbour_2020_oi_190116.pdf

Reference29 articles.

1. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.;Bradley;Lancet Oncol,2015

2. Sequential vs concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.;Curran;J Natl Cancer Inst,2011